Evidence map›Paper›PMID 30717135›Full record

ArticleMarine drugs2019

Novel Antimicrobial Indolepyrazines A and B from the Marine-Associated

Komal Anjum, Sidra Kaleem, Wenwen Yi, Guowan Zheng, Xiaoyuan Lian, Zhizhen Zhang

Abstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Life (Basel, Switzerland) · 2023
    Review
  4. Anti-Candidal Marine Natural Products: A Review.Journal of fungi (Basel, Switzerland) · 2023
    Review
  5. Review
  6. Marine Compounds with Anti-Journal of fungi (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Komal AnjumCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. komalazam@ymail.com.
Sidra KaleemOcean College, Zhoushan Campus, Zhejiang University, Zhoushan 316021, China. kaleemsidra85@yahoo.com.
Wenwen YiOcean College, Zhoushan Campus, Zhejiang University, Zhoushan 316021, China. 18790658213@163.com.
Guowan ZhengCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. 0818331@163.com.
Xiaoyuan LianCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. xylian@zju.edu.cn.
Zhizhen ZhangOcean College, Zhoushan Campus, Zhejiang University, Zhoushan 316021, China. zzhang88@zju.edu.cn.ORCID 0000-0002-8290-3507

Funding

he National Natural Science Foundation of China 81773587 and 81773769the National Key R&D Program of China 2017YFE0102200
6 · The paper itself

Abstract

Two new alkaloids indolepyrazines A (

Indexed as

AcinetobacterAnti-Bacterial AgentsCandida albicansCircular DichroismEscherichia coliIndole AlkaloidsMagnetic Resonance ImagingMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPyrazinesAnti-Bacterial AgentsIndole AlkaloidsPyrazinesAcinetobacter sp. ZZ1275Antimicrobial activitiesIndolepyrazines A and B

Identifiers

PMID30717135
PMCPMC6410138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.